Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-46441 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- FAM83A Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Peptide sequence: ANGRLSSSSG SASDRTSSNP FSGRSAGSHP VPESKQNKTK TKKQTTLWFL
- Concentration
- 0.5 mg/mL
Submitted references miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A.
Liu C, Jiang Y, Han B
Cancer management and research 2020;12:12623-12633
Cancer management and research 2020;12:12623-12633
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of fetal liver cell lysate using an anti-FAM83A polyclonal antibody (Product # PA5-46441).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 6 FAM83A partially reverse miR-613 mediated tumor suppression function. ( A ) BT20 cells with miR-613 overexpression were transfected with FAM83A plasmid and Hs578T cells with miR-613 inhibition were transfected with FAM83A siRNAs. The cell proliferation assay was performed in the aforementioned cells. Western blot is used to validate the expression of FAM83A. The colony formation assay ( B ), Apoptosis assay ( C ) and spheroid formation assay ( D ) were performed in the aforementioned cells. * p
